Crossref
With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile
The Journal of Community and Supportive Oncology · 2013
DOI: 10.12788/j.cmonc.0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2013. Verfasst von John Fracchia.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fracchia, J. (2013). With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/j.cmonc.0012
Vancouver
Fracchia J. With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile. The Journal of Community and Supportive Oncology. 2013. doi:10.12788/j.cmonc.0012
BibTeX
@article{Fracchia2013,
author = {Fracchia, John},
title = {With enzalutamide for prostate cancer, it may all depend on the tumor’s AR profile},
journal = {The Journal of Community and Supportive Oncology},
year = {2013},
doi = {10.12788/j.cmonc.0012}
}
EUVIMED